Search
Lifestance Health Group Inc
LFSTAdd to Watchlist
8.980USD
+0.370+4.30%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
3.49BMarket Cap
149.77P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Lifestance Health Group Inc is 8.00, ranking 29 out of 76 in the Healthcare Providers & Services industry. The average price target is 8.25, with a high of 10.00 and a low of 6.50.
Analyst Rating
Based on
12
analysts
Buy
Current Rating
10.389
Target Price
+15.69%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
8
Median
9
Average
Company name
Ratings
Analysts
Lifestance Health Group Inc
LFST
12
CVS Health Corp
CVS
29
Teladoc Health Inc
TDOC
27
HCA Healthcare Inc
HCA
26
Natera Inc
NTRA
23
Tenet Healthcare Corp
THC
23
1
2
3
...
14
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Lifestance Health Group Inc's expected revenue for the next quarter?
Lifestance Health Group Inc's expected revenue is 414.37M.
What is Lifestance Health Group Inc's price target?
Analysts forecast that Lifestance Health Group Inc's price target is USD 8.25, with the highest forecast at USD 10.00 and the lowest forecast at USD 6.50.
How have Lifestance Health Group IncLFST's recent earnings per share performed?
The market expectation was USD 0.04, while Lifestance Health Group IncLFST's earnings per share (EPS) for the previous quarter was USD 0.03. EPS for the next quarter is expected at USD 0.04.
What is the analyst rating for Lifestance Health Group Inc?
Based on the ratings of Lifestance Health Group Inc's stock from 12 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
